As of December 2024, VentriPoint Diagnostics has a market cap of $21.17M. This makes VentriPoint Diagnostics the world's 29804th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $36.87M | 3.03% |
2023 | $35.79M | 19.72% |
2022 | $29.89M | -31.93% |
2021 | $43.91M | 250.00% |
2020 | $12.55M | 52.91% |
2019 | $8.21M | -53.29% |
2018 | $17.56M | -52.10% |
2017 | $36.67M | 194.46% |
2016 | $12.45M | -50.34% |
2015 | $25.08M | -62.90% |
2014 | $67.59M | -32.34% |
2013 | $99.90M | -57.25% |
2012 | $233.67M | 0.00% |
2011 | $233.67M | 0.00% |
2010 | $233.67M | - |